Skip to content

MRNA

Moderna, Inc.

Cash flow statement

Cash flow statement
Line, in USDLast 12 months2025202420232022202120202019201820172016
Operating cash flow−1.8B−1.9B−3.0B−3.1B5.0B13.6B2.0B−459M−331M−331M67M
0.19B0.19B1.05B0.71B0.40B0.28B68M32M0.11B58M33M
Free cash flow−2.0B−2.1B−4.1B−3.8B4.6B13.3B2.0B−491M−437M−390M34M
Depreciation and amortization239M211M185M617M348M232M31M31M25M21M15M
Stock-based compensation464M483M429M305M226M142M93M81M73M40M39M
Buybacks—2.0M01.15B3.33B0.86B00———
Free cash flow margin−78.0%−106.2%−125.3%−55.9%23.8%72.2%244.0%−818.3%−323.3%−189.4%31.0%